A detailed history of Wulff, Hansen & Co. transactions in Danaher Corp stock. As of the latest transaction made, Wulff, Hansen & Co. holds 1,248 shares of DHR stock, worth $275,109. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,248
Previous 2,156 42.12%
Holding current value
$275,109
Previous $425,000 41.88%
% of portfolio
0.22%
Previous 0.4%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025

SELL
$181.46 - $212.2 $164,765 - $192,677
-908 Reduced 42.12%
1,248 $247,000
Q2 2025

Aug 12, 2025

SELL
$174.64 - $205.16 $23,576 - $27,696
-135 Reduced 5.89%
2,156 $425,000
Q1 2025

May 14, 2025

BUY
$201.62 - $250.59 $461,911 - $574,101
2,291 New
2,291 $469,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $160B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Wulff, Hansen & Co. Portfolio

Follow Wulff, Hansen & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wulff, Hansen & Co., based on Form 13F filings with the SEC.

News

Stay updated on Wulff, Hansen & Co. with notifications on news.